Discontinuation report HEPTOVIR
Report ID | 160503 |
Drug Identification Number | 02239194 |
Brand name | HEPTOVIR |
Common or Proper name | lamivudine oral solution |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LAMIVUDINE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | All pack sizes / Tous les formats |
ATC code | J05AF |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-07-13 |
Remaining supply date | 2023-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-07-22 | French | Compare |
v3 | 2022-07-22 | English | Compare |
v2 | 2022-05-13 | French | Compare |
v1 | 2022-05-13 | English | Compare |
Showing 1 to 4 of 4